Mirvetuximab after anaphylaxis to Paclitaxel: A case report

• Principais autores: Megan A. Stewart (Autor), Taylor A. Rives (Autor), Kimberly Blanton (Autor), Lauren Baldwin (Autor)
• Formato: Livro
• Publicado em: Elsevier, 2024-08-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Introduction: Patients with platinum resistant epithelial ovarian cancer have limited treatment options which are further limited by hypersensitivity reactions to first line medications such as paclitaxel. Paclitaxel is a taxane that inhibits microtubules and has a high incidence of hypersensitivity...